Combined occipital and supraorbital nerve stimulation for treatment of refractory migraine headaches

Abstract

Chronic refractory migraine is estimated to affect 1.3 – 5.1% of the global population (1) Once medical therapies and other conservative have been exhausted, patients with migraine often have little choice but to self-manage their symptoms. (2) Neuromodulation is a possible treatment that can improve their lives and reduce their medications. Occipital Nerve Stimulation has been used in various primary headache syndromes with positive results. (3,4, 5)